Vitamin E and CVD
This article was originally published in The Tan Sheet
Executive Summary
Natural source vitamin E (400 IU/day) has neutral effect on arterial plaque and other heart disease risk factors, subset study of Heart Outcomes Prevention Evaluation finds. "There were no differences in atherosclerosis progression rates between patients on vitamin E and those on placebo," SECURE study researchers Eva Lonn, MD, McMaster University, Hamilton, Ontario, et al. say in Feb. 20 issue of Circulation. The 732-patient Study to Evaluate Carotid Ultrasound Changes in Patients Treated with Ramipril and Vitamin E was part of the HOPE trial, which found similar results regarding the nutrient (1"The Tan Sheet" Jan. 24, 2000, p. 11)
You may also be interested in...
Vitamin E Cardiovascular Benefits Disputed In HOPE Study
Long-term daily vitamin E supplementation has no apparent effect on cardiovascular outcomes in high-risk individuals 55 years and older, Heart Outcomes Prevention Evaluation Study (HOPE) investigators report in the Jan. 20 New England Journal of Medicine.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands